As on Wednesday, CorMedix Inc (NASDAQ: CRMD) started slowly as it slid -6.42% to $13.7, before settling in for the price of $14.64 at the close. Taking a more long-term approach, CRMD posted a 52-week range of $5.31-$17.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 29.80% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 29.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 642.78%. This publicly-traded company’s shares outstanding now amounts to $74.62 million, simultaneously with a float of $66.88 million. The organization now has a market capitalization sitting at $1.02 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.33, while the 200-day Moving Average is $10.81.
CorMedix Inc (CRMD) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. CorMedix Inc’s current insider ownership accounts for 10.40%, in contrast to 46.12% institutional ownership. Preceding that transaction, on Oct 31 ’24, Company’s EVP, Chief Commercial Officer bought 1,500 for 9.99, making the whole transaction’s value amount to 14,985. This particular insider is now the holder of 52,011 in total.
CorMedix Inc (CRMD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.66 per share during the current fiscal year. CorMedix Inc’s EPS increase for this current 12-month fiscal period is 642.78% and is forecasted to reach 2.33 in the upcoming year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Let’s observe the current performance indicators for CorMedix Inc (CRMD). It’s Quick Ratio in the last reported quarter now stands at 7.52. Alongside those numbers, its PE Ratio stands at $18.35, and its Beta score is 1.91. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.42. Similarly, its price to free cash flow for trailing twelve months is now 33.63.
In the same vein, CRMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.75, a figure that is expected to reach 0.38 in the next quarter, and analysts are predicting that it will be 2.33 at the market close of one year from today.
Technical Analysis of CorMedix Inc (CRMD)
Through scrutinizing the latest numbers posted by the [CorMedix Inc, CRMD], it can be observed that its last 5-days Average volume of 8.35 million was better the volume of 2.14 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 66.71% While, its Average True Range was 54.16%.
Raw Stochastic average of CorMedix Inc (CRMD) in the period of the previous 100 days is set at 65.24%, which indicates a major rise in contrast to 59.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.67 that was higher than 0.63 volatility it exhibited in the past 100-days period.
